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Abstract 
Background: Endobronchial ultrasonography (EBUS) is useful to assess the laminar 
structure of the bronchial wall. The purpose of this study was to assess the 
comparability of EBUS with high resolution CT (HRCT) for measuring whole bronchial 
wall thickness and to validate the use of EBUS as a tool for the assessment of bronchial 
wall structures in asthma.   
Methods: Ten patients with stable asthma and eleven patients without asthma were 
studied. EBUS was performed with a radial 20-MHz ultrasonic probe into the 
intermediate bronchus undergoing fiberoptic bronchoscopies to assess the each layers of 
airway wall.   A cross-section of the apical bronchus of the right upper lobe was 
examined from HRCT. The percentage airway wall thickness (WT%; defined as [(ideal 
outer diameter – ideal luminal diameter)/ideal outer diameter] x 100) and the percentage 
airway wall area (WA%; defined as (wall area/total airway area) x 100) were 
determined from both EBUS and HRCT to assess whole airway wall thickness. 
Bronchial hypereresponsivness was measured by inhalation of increasing concentration 
of methacholine using tidal breathing method.  
Results: WT% and WA% measured by EBUS image were significantly higher in the 
patients with asthma than without asthma, respectively (p<0.01, p<0.01). WT% and 
WA% of the intermediate bronchus measured by EBUS were positively correlated with 
those of the right apical bronchus measured by HRCT images, respectively (r=0.72, 
p<0.01 and r=0.72, p<0.01). The thickness of the second layer of the patients with 
asthma was grater than that of the patients without asthma when evaluating laminar 
structure by using EBUS (p<0.05). PC20-FEV1 was negatively correlated with the 
thickness of the second layer (r= -0.67, p<0.05). 
Conclusion: EBUS is able to evaluate the five different layers of cartilaginous bronchi. 
Therefore, EBUS may be useful to assess airway wall remodeling by evaluating 







    Airway wall thickening in patients dying of asthmatic attacks results from 
inflammation with edema and inflammatory cell infiltration and from structural changes, 
such as subepithelial fibrosis, mucous gland and goblet cell hyperplasia, and smooth 
muscle hypertrophy and hyperplasia (1,2). This structural change is considered a feature 
of airway wall remodeling, which is resulted from chronic inflammation (3-5). This 
thicking could be as important as smooth muscle shortening in determining the airway 
responsiveness of asthmatic patients (6).   
Remodelling of the airway wall has been assessed using bronchial biopsy 
specimens (3,7-13) as well as inflammatory changes of airway using high resolution 
computed tomography (HRCT) (14-19). The assesment using HRCT technique involved 
radiation risk and is not applicable for bronchial mural structure. The invasive 
diagnostic tools such as bronchial biopsy using fiberoptic bronchoscopy is risk for 
hemorrhage from biopsied bronchial wall. Furthermore, it is often difficult to analysis 
the laminar structure of bronchial wall because of insufficient and/or damaged 
specimens.   
The endobronchial ultrasonography (EBUS) is successfully used for the 
assessment of mediastinal lymph nodes and other mediastinal structures (20,21).  
Recently, EBUS has been shown to be useful to assess the laminar structure of the 
bronchial wall (22-27). The needle puncture experimental studies showed that the 
correlation between the ultrasonographic images and the bronchial wall structure have 
been clarified (22,24). To our knowledge, it has not yet been studied on the sonographic 
layer structure in the patient with asthma. 
The purpose of this study was to assess the comparability of EBUS with HRCT for 
measuring whole bronchial wall thickness and to validate the use of EBUS as a tool for 
the assessment of bronchial wall structures in patients with asthma. In addition, we 





  Ten patients with stable asthma diagnosed according to American Thoracic Society 
criteria (28) and eleven non-asthmatic subjects without respiratory symptom were 
studied. The study was approved by the Ethics Committee of our hospital (National 
Hospital Organization Kanazawa Medical Center, Kanazawa, Japan) and written 
informed consent from the patients was obtained.   
 
Fiberoptic Bronchoscopy 
  Subjects were given the intramuscular administration of 0.5 g of atropine sulfate, and 
25 mg of hydroxyzine and the intravascular administration of 0.1 mg of midazolam. 
Topical anesthesia was obtained with the inhalation of 4 percent lidocaine and 2 percent 
lidocaine sprayed into the oral passage, directly instilled onto the vocal cords, and used 
as needed on the bronchial mucosa.  
 
Endobronchial ultrasonography and assessment of bronchial wall thickness 
  For the endobronchial ultrasonography (EU-M 20 Endoscopic Ultrasound System; 
Olympus, Tokyo, Japan), a 2.6mm-diameter, 20-MHz frequency radial mechanical 
transducer type ultrasonic probe (UM-BS20-26R; Olympus; Tokyo, Japan) and a 
flexible balloon sheath that was equipped with a balloon at the tip (MAJ-643R; 
Olympus; Tokyo) were utilized. We introduced them through the 2.8-mm-diameter 
channel of a flexible bronchoscope (model IT-260; Olympus; Tokyo, Japan). The 
balloon sheath was inflated three times into the intermediate bronchus, to the minimun 
amount saline required to cause contact with the airway wall and obtain a 360° image.  
The image by EBUS revealed the layered structure of the bronchial wall, which was 
recorded on paper (UP-880 Video Graphic Printer; Sony; Tokyo, Japan) and videotape 
(22).   
  We decided to take the cartilaginous portion of the bronchial wall into detailed 
consideration. From cartilage containing parts of bronchial wall, three EBUS images 
showing the most obvious and well-defined laminar structure was selected by a blinded.  
All airway measurements were conducted by a single observer in a blind fashion.  
Firstly, we measured the whole bronchial wall thickness (WT) and whole wall area 
(WA). WT was defined as (outer diameter - inner diameter). Ideal outer diameter (Do) 
and ideal luminal diameter (DL) were calculated as by tracing the external and internal 
perimeters, respectively. These parameters were measured directly using electric 
calipers. Percentage wall thickness (WT%) was defined as [(Do-DL)/Do] x 100. Whole 
wall area is defined as [total airway area (Ao) - luminal area (Al)]. Percentage wall area 
(WA%) was defined as [(Ao-Al)/Ao] x 100. These parameters, including WT% and 
WA%, were calculated from a mean of three EBUS images (26). 
  Secondly, the thickness of each layer was measured (Fig.1). The cartilaginous portion 
of the extrapulmonary bronchi is visualized as five layers (21). The absolute values of 
the thickness of each layer were measured. The mean values of the three EBUS images 
were used.    
 
High Resolution Computerd Tomography (HRCT) and the assesment of wall thickness 
  The thoracic HRCT scan system was performed at 120 KVp, 250 mA, 1 mm 
collimation, and pitch 1.0. To obtain one section through the apical segmental bronchus, 
3.8 cm of lung were scanned in the helical section. The starting point of the scan was 
determined on scout film according to this value, assuming that scanning would be 
terminated at the origin of the right upper lobe bronchus. Images were reconstructed 
using the FC10 algorithm at 1-mm spacings. A targeted reconstruction of the right lung 
was performed using a subject-specific field of view (FOV) (153 mm). Each image was 
composed of a 512 x 512 matrix of numeric data (CT numbers) in HU (18). 
  Image analysis was carried out using ExaVision from Zaiosoftwre. Ideal outer 
diameter was calculated as outer perimeter/π. Ideal luminal diameter was calculated as 
internal perimeter/π. Wall thickness (WT) was defined as outer diameter – luminal 
diameter. WT% was equal to WT/Do ratio in percentage. Wall area was defined as total 
airway area - luminal area. Total wall area and luminal area were traced and calculated 
on the personal computer. WA% was equal to WA/Ao ratio in percentage. These 
parameters were calculated from a mean of three HRCT images. These parameters were 
calculated from a mean of three HRCT images.  
 
Methacholine Challenge 
  Methacholine was dissolved in physiological saline solution to produce doubling 
concentrations of 0.04, 0.08, 0.16, 0.31, 0.63, 1.25, 2.5, 5, 10, 20, 40, 80 and 160 mg/ml.  
Saline and each concentration of methacholine were inhaled from a DeVilbiss 646 
nebulizer (DeVilbiss Co., Somerset, PA) operated by compressed air at 5 L/min. The 
nebulizer output was 0.14 ml/min. Saline was inhaled first for 2 min and FEV1 was 
measured. If the change in FEV1 from the baseline value was less than 10%, inhalation 
of methacholine was started, and if the saline solution caused 10% or more change in 
FEV1, the test was stopped or postponed. Methacholine was inhaled for 2 min by tidal 
mouth breathing, and this was followed immediately by three measurements of 
flow-volume curves at 1-min intervals; the curve with the largest FVC was retained for 
analysis. Increasing concentrations of methacholine were inhaled until decrease of 20% 
or more in FEV1 occurred. 
 
Statistical analysis 
  Data were expressed as means ± SD and analyzed with the StatView 5.0 program 
(SAS Institute, Cary, NC). An unpaired t test, the Mann-Whitney U test was used to 
compare groups. Spearman’s rank correlation test or Pearson’s correlation test was used 




Patient’s characteristics  
  The characteristics of the patients with asthma and non-asthmatic subjects are 
summarized in Table1. Eleven non-asthmatic subjects included 5 patients with lung 
cancer, 1 granuloma, 1 mediastinal lymphadenopathy and 4 others (Table1). The mean 
(SD) FEV1, %predicted FEV1 and FEV1/FVC ratio were 1.70 (0.39) L, 67.2 (12.8) % 
and 57.4 (16.1) %, respectively, in the patients with asthma, and those values were 
significantly lower than those in the non-asthmatic subjects, respectively (p<0.01). The 
geometric mean (geometric standard error of the mean) PC20-FEV1 was 0.88 (1.27) in 
the patients with asthma, which was lower than that those in the non-asthmatic subjects 
(p<0.01). 
 
Whole bronchial wall thickness measured by EBUS and HRCT 
  The mean (SD) WT% measured by EBUS images was 27.9 (4.2) % in the patients 
with asthma and 18.9 (2.6) % in the non-asthmatic subjects (Fig.2). The mean (SD) 
WA% measured by EBUS images was 47.9 (6.0) % in the patients with asthma and 34.2 
(4.2) % in the non-asthmatics (Fig.3). WT% and WA% measured by EBUS images were 
significantly higher in the patients with asthma than those in the non-asthmatic subjects, 
respectively (p<0.01, p<0.01). 
  The mean (SD) WT% measured by HRCT was 35.3 (5.1) % in the patients with 
asthma and 28.1 (4.1) % in the patients without asthma. The mean (SD) WA% measured 
by HRCT was 58.0 (6.4) % in the asthmatic patients and 48.1(6.1) % in the 
non-asthmatic patients. The WT% and WA% measured by HRCT images were 
significantly greater in the asthmatics compared with those in the non-asthmatics, 
respectively (p<0.05, p<0.05). 
 
Relationship between WT% and WA% measured by EBUS and HRCT 
  WT% and WA% measured by EBUS images were positively correlated with those 
measured by HRCT images, respectively (r=0.721, p<0.01 and r=0.724, p<0.01) (Fig.4 
and Fig.5). 
 
Detail of five layers of airway and bronchial responsiveness to methacholine 
  Thickness of the five layers (1: hyperechoic marginal echo, 2: hypoechoic 
submucosal tissue, 3: hyperechoic inner marginal echo of the cartilage, 4: hypoechoic 
cartilage, 5: hyperechoic outer marginal echo of the cartilage) was measured by EBUS 
in the asthmatic patients and non-asthmatic subjects (Figure 6). The mean (SD) values 
of thickness were 0.37 (0.12), 0.36 (0.09), 0.32 (0.06), 0.66 (0.12) and 0.41 (0.21) mm 
for the layers 1, 2, 3, 4 and 5 in the patients with asthma and 0.29 (0.08), 0.28 (0.06), 
0.27 (0.08), 0.60 (0.25) and 0.37 (0.11) in the patient without asthma, respectively. The 
thickness of the 2nd layer in the patients with asthma was significantly grater than that 
in the patients without asthma (P<0.05) (Fig.7). 
  In the patient with asthma, PC20-FEV1 was significantly and negatively correlated 
with the thickness of the 2nd layer (r= -0.67, p<0.05). In contrast, there was no 




This is the first study, to our knowledge, to investigate the relationship between 
airway wall thickness, as assessed by EBUS and HRCT scan, and bronchial 
responsiveness, measured in the patients with asthma. Airway wall thickeness (WT% 
and WA% in large airway) measured by EBUS image were significantly higher in the 
patients with asthma than those in the patients without asthma. Airway wall thickness 
(WT% and WA% in large airway, such as intermediate bronchus) measured by EBUS 
images were positively correlated with those of the apical segmental bronchus of the 
right upper lobe measured by HRCT images. Furthermore, we found that the thickness 
of the second layer in large airway was greater in the patient with asthma than in 
without asthma using EBUS images. The thickeness of the second layer assessed by 
EBUS examination was positively correlated with non-specific bronchial 
responsiveness in the patients with asthma.  
Wall thickness results from inflammatory changes, such as edema and inflammatory 
cell infiltration, and from structual changes, such as mucous gland hyperplasia, reticular 
basement membrane thickening, vascular prolification, and airway smooth muscle 
hypertrophy and hyperplasia. These structural changes are features of airway 
remodeling associated with chronic inflammation (7). Airway wall thickening may thus 
lead to airway hyperresponsiveness (AHR), an essential feature of asthma (29,30).  
HRCT has been used to measure airway wall dimensions in patients with asthma 
(15-19). Patients with asthma have thicker airways on HRCT scan than healthy control 
subjects have (15-18), and the degree of thickening is related to the severity of disase 
(16,17,19), airflow obstruction (17,18) and AHR (31). In this study, the apical segment 
of the right upper lobe was chosen for its convenient orientaion, so that the CT images 
aviod tangential cuts through the airway (17).  
EBUS is a noninvasive and safe method to assess mediastinal lymph node, other 
mediastinal structure and the laminar structure of the bronchial wall (20-26). The 
subjects did not feel the discomfort, such as dyspnea or coughing associated with the 
procedure in this study. It is proper that we should perform EBUS study at the apical 
segmental bronchus of the right lung, the same bronchus measured by HRCT. But, the 
apical segment of the right upper lobe cannot be accessed by using a 20-MHz ultrasonic 
probe since the transducer is too rigid to permit entry into this lung segment (26).  
Therefore, we performed EBUS at the large airway, intermediate bronchus, but not 
apical segmental bronchus of the right lung measured by HRCT study. Ultrasound 
images obtained in this large airway were clear enough to assess not only each layer of 
bronchial wall but also whole bronchial wall. 
Recently, Irani et al showed that EBUS was useful to identify and quantitatively 
assess bronchial wall structure in lung transplant recipients (27). We were able to 
discriminate the previously described multilayer structure of the airway wall at this 
localization (20,22-25). Kurimoto et al have reported that the first layer (hyperechoic 
layer) is a marginal echo extended from the inner margin of the mucosal epithelium to 
the inner part of the mucosal tissue, the second layer (hypoechoic) is the outer part of 
mucosal tissue, the third layer (hyperechoic) is marginal echo on the inside of cartilage, 
the fourth layer (hypoechoic) is cartilage, and the fifth layer (hyperechoic) is marginal 
echo on the outside of the cartilage in needle-puncture experiment (22). In this study, 
the thickness of the second layer was higher in the patient with asthma than without 
asthma. As the second layer is equal to the large part of submucosal tissue containing 
airway smooth muscle (22), we found that the thickness of submucosal layer in the 
patient with asthma was greater than that in non-asthmatic subjects using EBUS 
technique. The thickness of the second layer was positively corelated with bronchial 
responsiveness in the patient with asthma. In contrast, the thickness of whole bronchial 
wall was not correlated with bronchial responsiveness in the patient with asthma. As the 
techinique of EBUS involved the inflation of a saline-filled baloon around the 
ultrasound probe, we were concerned that the saline-filled baloon may compress the 
airway and alter the whole wall thickness measures. Shaw et al reported that ultrasound 
images recorded from the sheep airways in vitro study, with the baloon inflated, 
demonstrated a slightly greater airway wall thickness (~0.5 mm) than when it was 
deflated, although this difference did not rearch statistical significance (26). When the 
latex baloon sheath is in contact with the airway, its thickness is included in the 
measured thickness of the first layer. As the thickness of the first layer of this ultrasound 
image contains at least the three componet, latex baloon, epithelium and a inner part of 
sumucosal tissue, we can not exactly evaluate the length of epitelium in the patients 
with asthma. The resolution of the 20-MHz ultrasound probe is limited, which explains 
why the borders of the particular layers appear blurred. A 30-MHz probe providing a 
higer image resolution has been developed (25). Future studies using this new 
equipment is required.  
We conclude that the thickness of whole airway and submucosal layer measured by 
EBUS image are significantly higher in patients with asthma than in non-asthmatic 
subjects. Furthermore, we showed positive correlation of bronchial responsiveness with 
the thickness of the submucosal tissue measured by endobronchial ultrasound, but not 
with whole airway wall thickness determined by HRCT in patients with asthma. This 
study suggests that the thickness of the second layer (hypoechoic submucosal layer) 
might be partially related to the degree of bronchial responsiveness in patients with 
asthma. The endobronchial ultrasound is a useful technique to evaluate a distinct 
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Legend for figures 
Fig.1: Indices of airway wall thickness on EBUS and HRCT scan. 
Ftg.2: WT% measured by EBUS in asthmatic patients and non-asthmatic subjects. 
WT% measured by EBUS image differed significantly between patients without asthma 
(open circle) and patients with asthma (shaded circle) (p<0.01). Error bars are expressed 
as mean (SD).  
Fig.3: WA% measured by EBUS in patients with asthma (shaded circle) and subjects 
without asthma (open circle). WA% measured by EBUS image differed significantly 
between asthmatic patients (open circle) and non-asthmatic subjects (shaded circle) 
(p<0.01). Error bars are expressed as mean (SD). 
Fig.4: Relationship between WT% measured by EBUS and HRCT.  
WT% measured by EBUS images were positively correlated with those measured by 
HRCT images (r=0.721, p<0.01).  
Fig.5: Relationship between WA% measured by EBUS and HRCT. WA% measured by 
EBUS images were positively correlated with those measured by HRCT images 
(r=0.724, p<0.01).  
Fig.6: Analysis of each layer of bronchial wall (the right intermediate bronchus) using 
EBUS. The left, A: Definition of the cartilaginous portion to be measured; the sector 
starts in the center of the bronchus. The right, B: Measurement of the absolute thickness 
of each layer.  
Fig.7: Thickness of the five layers (1: hyperechoic marginal echo, 2: hypoechoic 
submucosal tissue, 3: hyperechoic inner marginal echo of the cartilage, 4: hypoechoic 
cartilage, 5: hyperechoic outer marginal echo of the cartilage) measured in patient 
without asthma (open column) vs. patients with asthma (closed column). The thickness 
of the 2nd layer in patients with asthma was significantly greater than that in 
non-asthmatic subjects (P<0.05). Error bars are expressed as mean (SD).  
WA(airway wall area)
Ao (total wall area)
Al (luminal area)
= Do (outer diameter)
Figure 1: Indices of airway wall thickness on EBUS and HRCT scan.
WA% (percent wall area) = WA/Aoｘ100
WT% (percent wall thickness) = WT/Doｘ100
t
(1) WT (whole bronchial wall thickness) 
(2) WA (whole bronchial wall area)










Error bars are expressed as mean (SD)

















Figure 4 : Correlation of WT% measured by EBUS and  HRCT 
EBUS (%)
HRCT (%)



























































**: p<0.01 compared with non-asthmatic group. Data are shown as Mean±SD. 
#: shown as geometric mean (geometric standard error of the mean).
Figue 6 : Layers of the bronchial wall by EBUS









Error bars are expressed as mean (SD)
1.0
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Figure 7 : The thickness of each layers of bronchial wall 
*
Figure 8 : Correlation of the thickness of 2nd layer and Log (PC20-
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